ASBP
NASDAQ · Pharmaceuticals
Aspire Biopharma Holdings In
$6.17
-0.12 (-1.91%)
Open$5.87
Previous Close$6.29
Day High$6.50
Day Low$5.63
52W High$1,050.00
52W Low—
Volume—
Avg Volume1.47M
Market Cap8.52M
P/E Ratio—
EPS$-168.87
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 161.1K | 2.20M | 2.09M |
| Net Income | -636,332,090 | 266.8K | 312.0K |
| Profit Margin | -394,852.4% | 12.1% | 14.9% |
| EBITDA | -512,463,433 | 501.0K | 520.7K |
| Free Cash Flow | — | 197.3K | 259.9K |
| Rev Growth | — | +5.7% | +22.2% |
| Debt/Equity | 0.00 | 0.42 | 0.41 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |